Nečistoty aminokyseliny používanej na syntézu proteínu
Detail produktu
| NO | Výrobky | CAS NIE | Indikátor kvality | |||
| Čistota | Max. nečistota | Celkový zvyšok rozpúšťadla | Vlhkosť | |||
| 1 | FMoc-p-ala-ala-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 2 | FMOC-D-ALA-D-ALA-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 3 | FMOC-P-ALA-D-ALA-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 4 | FMOC-ARG (PBF) -Arg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 5 | FMOC-P-ALA-ARG (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 6 | FMOC-D-Arg (PBF) -D-Arg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 7 | FMOC-P-ALA-D-ARG (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 8 | FMOC-homoarg (PBF) -Homoarg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 9 | FMOC-P-Ala-Homoarg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 10 | FMOC-ASN (TRT) -ASN (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 11 | FMOC-P-Ala-ASN (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 12 | FMOC-ASP (OTBU) -ASP (OTBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 13 | FMOC-P-ALA-ASP (OTBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 14 | FMoc-cys (TRT) -cys (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 15 | FMOC-β-ala-cys (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 16 | FMOC-CYS (ACM) -CYS (ACM) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 17 | FMOC-P-Ala-Cys (ACM) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 18 | FMoc-gln (trt) -gln (trt) -oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 19 | FMOC-P-Ala-Gln (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 20 | FMoc-glu (otbu) -glu (otbu) -oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 21 | FMOC-P-Ala-Glu (OTBU) -OH.H2O | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 22 | FMOC-β-ala-gly-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 23 | FMOC-His (TRT) -HIS (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 24 | FMOC-P-Ala-His (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 25 | FMOC-ILE-ILE-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 26 | FMOC-β-ala-ile-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 27 | FMoc-leu-leu-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 28 | FMoc-p-ala-leu-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 29 | FMoc-d-leu-d-leu-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 30 | FMoc-p-ala-d-leu-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 31 | FMOC-LYS (BOC) -LYS (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 32 | FMOC-P-Ala-LYS (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 33 | FMOC-LYS (Alloc) -LYS (Alloc) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 34 | FMOC-P-Ala-LYS (Alloc) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 35 | FMOC-MET-MET-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 36 | FMOC-P-ALA-MET-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 37 | FMOC-ern (BOC) -orn (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 38 | FMOC-β-ala-ren (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 39 | FMoc-phe-phe-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 40 | FMoc-p-ala-phe-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 41 | FMOC-D-PHE-D-PHE-OH-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 42 | FMOC-P-ALA-D-PHE-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 43 | FMOC-pro-pro-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 44 | FMOC-β-ala-pro-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 45 | FMOC-SER (TBU) -Ser (TBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 46 | FMOC-P-Ala-Ser (TBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 47 | FMOC-SER (TRT) -Ser (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 48 | FMOC-P-Ala-Ser (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 49 | FMOC-Thr (TBU) -Thr (TBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 50 | FMOC-P-Ala-Thr (TBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 51 | FMOC-TRP (BOC) -TRP (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 52 | FMOC-P-ALA-TRP (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 53 | FMOC-D-TRP (BOC) -D-TRP (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 54 | FMOC-P-ALA-D-TRP (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 55 | FMOC-Tyr (TBU) -tyr (TBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 56 | FMOC-P-ALA-TYR (TBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 57 | FMOC-D-Tyr (ET) -D-TYR (ET) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 58 | FMOC-P-ALA-D-TYR (ET) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 59 | FMOC-Tyr (me) -tyr (me) -oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 60 | FMOC-β-Ala-Tyr (ME) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 61 | FMOC-Val-Val-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 62 | FMOC-P-Ala-Val-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 63 | FMOC-D-cit-D-cit-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 64 | FMOC-P-ALA-D-CIT-OH-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 65 |
| NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 66 | FMoc- (3- (2-naftyl) -d-ala) 2-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 67 | FMOC-P-ALA-3- (2-naftyl) -D-ala-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 68 | FMoc- (3- (3-pyridinyl) -d-ala) 2-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 69 | FMOC-P-ALA-3- (3-pyridinyl) -D-ala-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 70 | FMOC- (4-chlór-d-phe) 2-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 71 | FMOC-P-ALA-4-chlór-D-Phe-OH-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 72 | FMoc- (D-4aph (TBUCBM)) 2-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 73 | FMOC-P-ALA-D-4APH (TBUCBM) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 74 | FMoc-Aph (L-Hor) -aph (L-Hor) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 75 | FMOC-P-Ala-Aph (L-Hor) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 76 | FMOC-LYS (IPR, BOC) -LYS (IPR, BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 77 | FMOC-P-Ala-LYS (IPR, BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 78 | FMoc-p-ala-aeea-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 79 | FMoc-aib-aib-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 80 | FMOC-β-ala-aib-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 81 | FMoc-arg-oh | 91000-69-0 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 82 | H-Arg (PBF) -OH | 200115-86-2 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 83 | FMOC-D-arg-oh | 130752-32-8 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 84 | HD-ARG (PBF) -OH | 200116-81-0 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 85 | FMOC-homoarg-oh.hcl | 208174-14-5 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 86 | H-Homoarg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 87 | FMOC-D-Homoarg-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 88 | HD-Homoarg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 89 | FMoc-asn-oh | 71989-16-7 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 90 | H-ASN (TRT) -OH | 132388-58-0 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 91 | FMOC-ASP-oh | 119062-05-4 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 92 | H-ASP (OTBU) -OH | 3057-74-7 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 93 | FMoc-cys-oh | 135248-89-4 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 94 | H-Cys (TRT) -OH | 2799/7/7 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 95 | H-Cys (ACM) -OH.HCl | 28798-28-9 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 96 | FMoc-gln-oh | 71989-20-3 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 97 | H-Gln (TRT) -OH | 102747-84-2 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 98 | FMoc-glu-oh | 121343-82-6 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 99 | H-glu (otbu) -oh.h2o | 2419-56-9 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 100 | FMoc-his-oh | 116611-64-4 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 101 | H-His (TRT) -OH | 35146-32-8 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 102 | Bok-his-oh | 17791-52-5 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 103 | FMoc-Lys-oh | 105047-45-8 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 104 | H-LYS (BOC) -OH | 2418-95-3 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 105 | H-LYS (Alloc) -OH | 6298/3/9 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 106 | FMoc-rern-oh.hcl | 201046-57-3 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 107 | H-ern (BOC) -OH | 13650-49-2 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 108 | FMoc-Ser-oh | 73724-45-5 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 109 | H-Ser (TBU) -OH | 18822-58-7 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 110 | H-Ser (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 111 | FMoc-thr-oh.h2o | 73731-37-0 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 112 | H-Thr (TBU) -OH | 4378-13-6 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 113 | FMOC-TRP-oh | 35737-15-6 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 114 | H-TRP (BOC) -OH | 146645-63-8 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 115 | FMOC-D-TRP-oh | 86123-11-7 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 116 | HD-TRP (BOC) -OH | 201290-11-1 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 117 | FMOC-Tyr-oh | 92954-90-0 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 118 | H-Tyr (TBU) -OH | 18822-59-8 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 119 | FMOC-D-Tyr-oh | 112883-29-1 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 120 | HD-Tyr (ET) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 121 | H-Tyr (me) -oh.hcl | 67423-44-3 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 122 | FMOC-D-4aph (CBM) -OH | 324017-22-3 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 123 | HD-4APH (TBUCBM) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 124 | FMOC-LYS (IPR) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 125 | H-LYS (IPR, BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
O
Kompenzácia
Spoločnosť Gentolex poskytuje výrobky kvality, ak klient získal akúkoľvek kvalitu produktu v požadovanom časovom rámci s dostatočnými dôkazmi, poskytneme potrebnú analýzu a hodnotenie na spustenie postupov kompenzácií.
Výroba
Kapacity farmaceutických výrobkov dosiahli tony, kapacity chemických výrobkov dosahujú 100tons+ stupeň, schopnosti sú dobre vybavené na to, aby slúžili klientom na celom svete.
Výskum
Každý rok je plán zriadený tímom výskumu a vývoja na vývoj rôznych nových produktov, keď sú stanovené ciele, každý člen v tíme bude musieť pokračovať v zodpovednosti KPI a s motivačnou politikou.
